SymBio Pharmaceuticals: Quarterly Report - 20th Quarter 1 (2024/01/01 - 2024/03/31)
SymBio Pharmaceuticals: Confirmation letter
SymBio Pharmaceuticals: Notice regarding revisions to the full-year earnings forecast for the fiscal year ending 2024/12
SymBio Pharmaceuticals: Summary of Financial Results for the 1st Quarter Ending 2024/12 [Japanese GAAP] (Consolidated)
SymBio Pharmaceuticals: Interim Report of Corrections
SymBio Pharmaceuticals: Extraordinary Report
SymBio Pharmaceuticals: Extraordinary Report
SymBio Pharmaceuticals: Confirmation letter
SymBio Pharmaceuticals: Financial Report - 19th Term (2023/01/01 - 2023/12/31)
SymBio Pharmaceuticals: Notice regarding the recording of impairment losses and differences between full-year consolidated earnings forecasts and actual values
SymBio Pharmaceuticals: Summary of Financial Results for the Fiscal Year Ending 2023/12 [Japanese GAAP] (Consolidated)
SymBio Pharmaceuticals: Confirmation letter
SymBio Pharmaceuticals: Quarterly Report - 19th Third Quarter (2023/07/01 - 2023/09/30)
SymBio Pharmaceuticals: Notice Concerning Revision of Full-Year Earnings Forecasts for the Fiscal Year Ending 2023/12 and Dissolution of Deferred Tax Assets
SymBio Pharmaceuticals: Summary of financial results for the 3rd quarter of the fiscal year ending December 31, 2023 [Japanese GAAP] (Consolidated)
SymBio Pharmaceuticals: Confirmation letter
SymBio Pharmaceuticals: Quarterly Report - Second Quarter 19th (2023/04/01 - 2023/06/30)
SymBio Pharmaceuticals: Notice regarding revisions to full-year earnings forecasts for the fiscal year ending 2023/12
SymBio Pharmaceuticals: Summary of Financial Results for the 2nd Quarter of the Fiscal Year Ending December 31, 2023 [Japanese GAAP] (Consolidated)
SymBio Pharmaceuticals: Confirmation letter
No Data